GSK PLC closed 30.68% below its 52-week high of £18.24, which the company achieved on May 16th.

ABL Bio and GSK enter into a multi-program agreement to develop novel medicines for neurodegenerative diseases ...

China, the world’s second largest economy after the US, is the hardest nut Trump is attempting to crack with his tariffs and he appears willing to go to extreme lengths to get his way. Last Wednesday, ...

NEW YORK, NY / ACCESS Newswire / April 7, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a potential ...

GSK PLC closed 26.98% short of its 52-week high of £18.24, which the company reached on May 16th.

GSK Plc and Pfizer Inc. settled a patent-infringement lawsuit over competing vaccines for RSV, ending the dispute in Delaware ...

Ms. Whitaker is an accomplished C-suite leader, most recently as Chair and CEO of Aerami Therapeutics Holdings Inc. During her executive career she has held senior leadership roles at GlaxoSmithKline ...

(Reuters) -British pharmaceutical giant GlaxoSmithKline and rival Pfizer have agreed to end a lawsuit that alleged Pfizer's ...

Pharmaceutical goods appear to be exempt from higher-rate tariffs introduced by President Trump in his 'Liberation Day' ...

UTI sufferers have a new treatment option—and it's the first new class of antibiotics the FDA has approved for urinary tract ...

US health regulators have approved a new antibiotic to treat urinary tract infections, a problem affecting more than 100 million people around the world, mainly women, British pharmaceutical giant GSK ...

The drug is a needed new option for treating uncomplicated UTIs, a common infection that’s becoming harder to treat as rates of microbial resistance rise.